Amanote Research

Amanote Research

    RegisterSign In

Cutaneous CD56 + T-Cell Lymphoma Developing During Pembrolizumab Treatment for Metastatic Melanoma

JAAD Case Reports - United States
doi 10.1016/j.jdcr.2018.01.016
Full Text
Open PDF
Abstract

Available in full text

Categories
Dermatology
Date

July 1, 2018

Authors
Yixuan James ZhengAlbert LeeLaura PincusWilson HoMarin VujicSusana Ortiz-Urda
Publisher

Elsevier BV


Related search

Pembrolizumab-Induced Sarcoid-Like Reactions During Treatment of Metastatic Melanoma

Radiology
Nuclear MedicineRadiologyImaging
2018English

Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Treatment of Cutaneous T-Cell Lymphoma: An Update

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1993English

Orphan Designation: Mogamulizumab, Treatment of Cutaneous T-Cell Lymphoma

Case Medical Research
2019English

Cutaneous T Cell Lymphoma (Mycosis Fungoides)

JMS SKIMS
2010English

Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Medical Journal Armed Forces India
Medicine
2007English

Menus for Managing Patients With Cutaneous T-Cell Lymphoma

Seminars in Cutaneous Medicine and Surgery
DermatologyMedicineSurgery
2012English

Cutaneous T-Cell Lymphoma With Nasal Necrosis

Archives of Plastic Surgery
Surgery
2015English

Cutaneous T-Cell Lymphoma Imitating Gelsolin Amyloidosis

Neurology
Neurology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy